Katherine Tryon1, Howard Bolnick, Jennifer L Pomeranz, Nicolaas Pronk, Derek Yach. 1. From The Vitality Institute (Drs Tryon and Yach), New York, NY; The Vitality Group (Mr Bolnick), Chicago, Ill.; Department of Public Health (Ms Pomeranz), Temple University, Philadelphia, PA; and Department of Society, Human Development and Health, Harvard School of Public Health (Dr Pronk), Boston, Mass.
Abstract
OBJECTIVE: Efforts to realize the potential of disease prevention in the United States have fallen behind those of peer countries, and workplace disease prevention is a major gap. This article investigates the reasons for this gap. METHODS: Literature review and expert discussions. RESULTS: Obstacles to effective use of workplace disease prevention include limited leadership and advocacy, poor alignment of financial incentives, limitations in research quality and investment, regulation that does not support evidence-based practice, and a dearth of community-employer partnerships. CONCLUSIONS: We make recommendations to address these obstacles, such as the inclusion of health metrics in corporate reporting, making the workplace a central component of the strategy to combat the effect of noncommunicable diseases, and linking prevention directly benefit businesses' bottom lines.
OBJECTIVE: Efforts to realize the potential of disease prevention in the United States have fallen behind those of peer countries, and workplace disease prevention is a major gap. This article investigates the reasons for this gap. METHODS: Literature review and expert discussions. RESULTS: Obstacles to effective use of workplace disease prevention include limited leadership and advocacy, poor alignment of financial incentives, limitations in research quality and investment, regulation that does not support evidence-based practice, and a dearth of community-employer partnerships. CONCLUSIONS: We make recommendations to address these obstacles, such as the inclusion of health metrics in corporate reporting, making the workplace a central component of the strategy to combat the effect of noncommunicable diseases, and linking prevention directly benefit businesses' bottom lines.
Authors: Deborah L McLellan; Alberto J Cabán-Martinez; Candace C Nelson; Nicolaas P Pronk; Jeffrey N Katz; Jennifer D Allen; Kia L Davis; Gregory R Wagner; Glorian Sorensen Journal: J Occup Environ Med Date: 2015-09 Impact factor: 2.162
Authors: Russell K McIntire; Martha C Romney; Greg Alonzo; Jill Hutt; Lauren Bartolome; Greg Wood; Gary Klein; Neil I Goldfarb Journal: Prev Chronic Dis Date: 2019-07-25 Impact factor: 2.830